INTRODUCTION
Ochratoxin A (OTA) is a mycotoxin produced by several Aspergillus and Penicillium species on different agricultural commodities [1] [2] [3] . It is a potent nephrotoxin and hepatotoxin with teratogenic, mutagenic and immunosuppres-sive effects. In humans, the consumption of OTA-contaminated food has been related to the occurrence of Balkan endemic nephropathy [4] , a disease characterized by severe kidney damage. In 1993, the International Agency for Research on Cancer (IARC) classified OTA as possibly carcinogenic for humans (group 2B) [5] . OTA occurs in a variety of food commodities of which cereals and cereal products, coffee, beer and wine are the most important sources of intake. Carry-over from contaminated feed-stuff has resulted in the detection of OTA in porcine tissue (liver, kidneys) and pig blood [6] while the mycotoxin is rapidly metabolized in ruminants [3] . Dietary exposure results in detectable levels in human serum and reaches significantly high levels in patients showing symptoms of ochratoxicosis [4] . Detection and determination of OTA is performed by immunochemical methods like enzyme linked immunosorbent assay (ELISA) [7] and chromatographic procedures, such as thin layer chromatography with densitometry detection [8] , and especially by high performance liquid chromatography with fluorescence (LC-FLD) [9, 10, 11] , mass spectrometry (LC-MS) [12] or tandem mass spectrometry (LC-MS-MS) detection [13] . Residue analysis should be simple and rapid to prevent the distribution of harmful products, but also economic enough to allow the development of programs for monitoring OTA over a wide number of food samples. Also, analytical methods for determination of mycotoxins must be fully validated according to the European specification [14] if they are to be used for the implementation of legislation and for monitoring and risk assessment studies. However, only a few of the methods found in the literature comply with these premises.
The purpose of this work was to develop a confirmative method which is sensitive, reliable, cost effective, rapid and adaptable to a routine work on the surveillance of ochratoxins A in pig tissues.
MATERIALS AND METHODS

Chemicals and reagents
OTA crystalline material was purchased from Sigma (St. Louis, MO, USA). Stock concentrated solution was prepared in toluene-acetic acid (99:1 v/v) at final concentration of 1 mg/ml, kept in security conditions at -20°C, and wrapped in aluminium foil due to the fact that OTA gradually breaks down under UV light. The OTA working solution was prepared by diluting the stock solution with toluene-acetic-acid (99:1 v/v) to å10 mg/ml. The actual concentration of OTA was calculated using UV spectrophotometer set at 333 nm (e 5.550). After suitable dilutions in water-methanol-acetic acid (50:49:1 v/v/v), the working solution was used to prepare the external calibration curve. A working standard OTA for HPLC was prepared just before starting the injection of a series of samples. Other reagents were HPLC grade. All other chemicals were reagent grade or chemically pure.
Sample collection
During a six month period (September 2006 /February 2007 , samples of blood, kidney and liver from each animal were collected from healthy slaughtered pigs (n = 90) originating from three different regions of Serbia where there is a significant swine industry. Slaughtered pigs were randomly sampled in the slaughterhouse during meat inspection. Serum samples were collected from each studied farm, and liver and kidneys were taken from the corresponding animals. About 50 ml blood/pig was sampled when slaughtered pigs were bled by jugular puncture. Blood samples remained at room temperature for 24 h to allow clotting to occur, and were then centrifuged at 3.000 x g for 20 minutes. Serum was decanted and stored at -20°C prior to analysis. About 100 g of liver and whole kidney were sampled from each pig. The whole sample was homogenized and stored at -20°C before analysis. No preservatives were added.
Extraction and clean-up for ochratoxin analyses from serum
Serum (0.8 ml) was extracted according to Curtui and Gareis [15] with 15% trichloroacetic acid (0.2 ml) and dichloromethane (1 ml) by vigorous vortexing for 30 s in a 2 ml safe-lock polypropylene conical-bottom centrifuge tube. The mixture was allowed to stand for 24 h at room temperature, and then centrifuged at 14.000 x g for 10 minutes. The lower dichloromethane phase was carefully withdrawn by a Pasteur pipette and transferred to a 1.5 ml safe--lock polypropylene conical bottom centrifuge tube. The acidic phase and the compact precipitate layer formed between the two phases were re-extracted with dichloromethane (0.5 ml) for 30 s on a vortex mixer and then centrifuged for 5 min at 14.000 x g. The pooled dichloromethane extract was evaporated to dryness at 40°C under a gentle nitrogen flow. The remaining residue was dissolved in methanol (80 ml) and transferred to a 300 µl HPLC vial.
Extraction and clean-up for ochratoxin analyses from kidney and liver
Kidney and liver analyses were performed by the method of Matrella et al. [16] , which briefly includes a double extraction with acidic ethyl acetate. The organic phase was removed and extracted with 0.5M NaHCO 3 , pH 8.4. The aqueous extract was acidified to pH-2.5 with 7M H 3 PO 4 . OTA was finally back extracted into ethyl acetate (3 ml). The organic phase was evaporated to dryness under N 2 steam, reconstituted in 150 ml mobile phases and a 20 ml aliquot injected.
Chromatographic conditions (HPLC)
An aliquot of 20 ml for serum samples and 50 ml for kidneys and liver samples were injected onto a Waters Symmetry Shield RP (Reversed phase) 18, high pressure liquid chromatography column (length and inner diameter 150 x 4,6 mm, particle size 5 mm) on a Waters Alliance HPLC system. The column was eluted with 4% acetic acid and acetonitrile (32:68 v/v) at 25°C and a flow rate of 1 ml/min. The measurements were performed by fluorescence detection at wavelengths of 334 nm (excitation) and 460 nm (emission) gains 10. The standards were injected with a volume of 10 ml, while the samples were injected with 20 ml. For more accuracy, 40 ml was re-injected in the case of the samples with an amount of OTA near the detection limit.
Confirmation procedures
Extraction and clean-up for ochratoxin analyses from serum, liver and kidney samples were performed by the methods described above [15, 16] . Sample extracts were evaporated to dryness under a gentle stream of nitrogen and stored at -18°C prior to analysis.
HPLC-FL after methylation of OTA
The methyl esters of ochratoxin A were prepared by adding 50 ml of methanol containing 14% of boron trifluoride (Sigma) to the evaporated sample extracts, and by keeping them at 80°C for 15 minutes [6] . Sample extracts were then evaporated to dryness under a gentle stream of nitrogen and stored at -18°C prior to analysis. Under the chromatographic conditions described above, the retention time of the methyl esters of OTA was in the range of 3.455 minutes.
Quantitation
Quantitation for the HPLC-FL method was performed using an external calibration curve from OTA and quantified using the standard addition method with calibration points set at 0.05, 0.1, 0.5, 1 and 3 ng/g.
Confirmation of OTA by liquid chromatography tandem mass spectrometric method (LC-MS/MS)
A Quattro II (Micro mass, UK) triple-quadrupole tandem mass spectrometer operated in the ESI+ mode using multiple reactions monitoring (MRM), and an atmospheric pressure chemical ionization (APCI) source was used. Data acquisition and processing, and instrument control were performed with Microsoft Windows based Mass Lynx software (Micro mass) on a Pentium Pro (Digital Equipment) computer. The following operating parameters were used: The electro spray capillary was set at 3.2 kV and the cone at 30 V. The ion source temperature was set at 115°C, and the flow rates for nitrogen bath and spray were 700 l/h and 55 l/h, respectively. The collision energy was 18 
Quantitation
External standard method. Calibration curves were constructed from the responses of each ion monitored plus the total ion current for OTA.
Linearity, detection limit, relative standard deviation and recovery
Fifteen blank samples were spiked with OTA standards at five different levels (0.05, 0.1, 0.5, 1 and 3 ng OTA/g). From the obtained responses (area of the mycotoxin divided by the area of the standard) the correlation coefficient (R) and limit of detection (LOD) were calculated. This LOD was verified by the signal-to-noise (S/N) ratio approach, measuring the chromatographic response of the compound and the chromatographic noise, which should be more than 3 for each compound. The coefficient of variation (C.V.) was calculated according to the five samples spiked at the same concentration level (the highest spiking level), which was performed under the same conditions. The overall recoveries of toxins were expressed as the mean recovery of three standards (n = 3) on two different days. The term recovery in this paper means the amount of substance obtained in the last quantification step (after the extraction) in relation to the amount of substance added to the material before the extraction, and is expressed as a percentage.
Statistical analyses
The arithmetic mean, standard deviation, the coefficient of variation (C.V. %), and the variance were calculated. The t test, double-sided, paired data, was used to determine the significance between the treatments.
RESULTS AND DISCUSSION
The results from these LC/MS/MS quantitation methods were compared with those from the conventional HPLC-Fl method and are summarized in Table 1 
Method performance by HPLC-FL
The limit of detection (LOD) (S/N, 3:1) and the limit of quantification (LOQ) (S/N, 7:1) were estimated at 0.05, 0.1, 0.5, 1 and 3 ng OTA/ml(g), and were 0.1 and 0.2 ng/ml for serum samples, while the recovery was 86.8% (C.V. = 9.6%). The limit of detection (LOD) (S/N, 3:1) and the limit of quantification (LOQ) (S/N, 7:1) for kidney and liver samples were 0.14 and 0.25 ng/g with a 71% (C.V. = 12%) mean recovery from artificially contaminated samples (n = 5).
Method performance by LC-MS/MS
The LOD and LOQ for serum were 0.20 and 0.40 ng/ml, while for kidney and liver were 0.25 and 0.50, respectively. Analyzed according to the proposed method, the recoveries obtained for kidney and liver samples, spiked at five levels (n = 5), ranged from 77 to 89% (C.V. = 13.9%). Application to the real sample
The proposed method of extraction, followed by HPLC-FL and LC-MS/ MS, was applied to 82 samples of serum, liver and kidney (Table 2) . Figures 1  and 2 show the HPLC-FL, before and after methylation procedure, and LC--MS/MS chromatograms obtained by the proposed extraction procedure for positive samples. For tissue samples, the obtained results are shown in Table 2 . The presence of OTA was detected by HPLC-FL in 82 out of 270 (30%) samples, whereas LC-MC/MS confirmed this in 78 samples. In 2.2% of the kidney samples, OTA levels were considerably higher and greatly exceeded the permissible levels of these toxins established in Serbia, including those proposed (10 ng/g) by the JECFA (2001) [17] . The presence of OTA was not detected by HPLC-FL, after methylation of OTA, in a positive sample which contained low levels of OTA (Figure 2 B1 and C1) . The presence of problems due to the coextractive substances in the matrix was also observed by Wood et al. (1995) [23], thus, a confirmation of the positive analysis was necessary. This problem was resolved with confirmation procedures achieved by LC-MS/MS. The main differences in the performance of the detection techniques can be divided into three aspects: (i) sensitivity, (ii) unambiguous identification of the analytes, and (iii) necessary selectivity of sample clean-up to obtain non--biased results. The excellent detection limits are certainly an advantage of HPLC-FL. On the other hand, the LOD for MS/MS detection is 0.2 ng/ml and 0.25 ng/g, which is comparable with an earlier LC-MS/MS investigation of OTA in samples of serum, liver and kidney. Triple-quadrupole analyzers display high sensitivity when working in multiple reaction monitoring (MRM) mode, and are, thus, best suited to obtain the strict MRLs regulated for various toxic compounds in different food matrices. However, the MS method could be made more sensitive by using more samples for the liquid-liquid or SPE procedure. Higher concentration of matrix constituents should not pose any problems since no interfering peaks were observed in the LC-MS-MS chromatograms (Figures 1 and 2) . Furthermore, MS sensitivity achieved in this and the previous study [19] can be considered sufficient to measure OTA concentrations in contaminated samples which could pose a threat to human health, taking WHO guidelines into account [20] .
Considering the unambiguous analyte identification, the fluorescence properties of OTA may not provide a sufficient degree of certainty. To counteract this disadvantage, confirmation procedures are mainly performed by derivatization of OTA into its methyl ester using BF3/MeOH and the subsequent de- termination of this compound. This method, however, poses two problems. First, the purity of the reagent employed is frequently uncertain so it itself could give rise to interferences [21] . Secondly, this method is not efficient for the confirmation of low levels of OTA [22, 23] . In the HPLC-FL chromatograms (Figure 2 B1 ) such signals are completely absent. Confirmation through the hydrolysis of OTA into OT¬ by the enzyme carboxypeptidase A is also employed in some studies and we have already used it for the confirmation of OTA in human plasma samples [24] . This procedure is no longer used in our laboratory because the identification of OTa is problematic due to its appearance at low retention time along with other substances in the sample. With MS/MS as a detection system, no further confirmation step is necessary, and this enables the avoidance of any error-prone derivatization steps and any further chromatographic analyses. In conclusion, the proposed method is an inexpensive, rapid, straightforward clean-up procedure for determining OTA in tissues, since around 10 samples can be processed per day.
CONCLUSION
A relatively high number of publications on the analyses of toxic substances in food samples by LC coupled with MS/MS shows that this technique has become a powerful tool in the quality control of food products and the safeguarding of human health. This paper has demonstrated excellent sensitivity and specificity of the LC-MS/MS method in the quantitative determination and confirmation of OTA in the samples of pig tissues at low-and sub-ppb levels. Despite lower sensitivity of the LC-MS/MS technique, this methodology has several advantages in terms of sample preparation, easy automatization and unambiguous analyte identification without any further time--consuming and error-prone confirmation steps. From this point of view, it seems that sample preparation and chromatographic separation may be simplified or even eliminated to achieve the highest possible sample throughput as, for example, in drug screening, pharmacokinetics and other areas of life sciences. The evaluation of the method with naturally contaminated samples demonstrated that the accuracy of the results is comparable to the most reliable HPLC-FL procedures, and that MS sensitivity is sufficiently high, taking into account the proposed OTA tolerance levels within the European Union. Since the detection of OTA in tissues of Serbian slaughtered swine that we analyzed serve as an end-point indicator of the widespread occurrence of OTA, it is important to determine which foods would be contaminated with this potent natural toxin. With the present analytical procedure, it should be possible to carry out surveillance on grains, animal feeds, meat, meat products and other foodstuffs to determine contamination levels of this toxin. As these techniques improve and become standardized, less controversial and more scientific evaluation of the human risks from exposure to mycotoxins will be possible [25] .
